In a peer-reviewed International Pharmaceutical Industry article, Tomislav Babic discusses biomarkers, clinical outcome measures, study design, and more for progressive multiple sclerosis.
Authors:
Tom Babic, MD, PhD
Vice President, Scientific Solutions, Neuroscience
